SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — History and Physical — Edward W. Brooke

PatientEdward W. Brooke
Date of birth1942-10-26
IdentifiersMRN HR-ML014-SYN; SSN (made up) 000-14-5063
Document date2026-01-13
AuthorHoward Bellamy, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

First visit to establish shared care for breast cancer on adjuvant tamoxifen, fourteen weeks after bilateral mastectomy and right axillary dissection [S]

History of Present Illness

This fictional modern episode addresses the presenting concerns below. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

2 later historical claims are omitted because they describe events after the index age. See the teaching note.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
September 2002Breast cancer of the right breast in a man, diagnosed after he noticed discomfort in the right breast; mammogram, sonogram, and needle biopsy; he had never had a chest examination by a doctor beforeD (CLM-0003)
2002Operation for breast cancer, reported as a double mastectomy, with removal of the lymph nodes on the right side, to which the cancer had spreadD (CLM-0004, CLM-0005)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Social History

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Tamoxifen 20 mg oral tablet, one tablet by mouth once daily (adjuvant endocrine therapy, planned for at least five years)One tablet once dailyOral route2025-10-28activeS

Review of Systems

Positive for the concerns in the history of present illness. Alert, articulate, and courteous; prefers to keep his diagnosis private for now and asks direct questions about his treatment. Mood good; PHQ-9 minimal at the first visit. No other systems reported as affected in this synthetic episode. [S]

General Status

Alert and engaged. Independent in all activities and instrumental activities of daily living; full shoulder movement on both sides after surgery. Walks 30 to 40 minutes most days. [S]

Physical Exam

Vital signs recorded on 2026-01-13; see the Vital Signs section. Mental status: Alert, articulate, and courteous; prefers to keep his diagnosis private for now and asks direct questions about his treatment; Mood good; PHQ-9 minimal at the first visit. The physical examination is limited to the findings relevant to this synthetic episode. [S]

Vital Signs

DateMeasureValueUnitProvenance
2026-01-13Body height183cmS
2026-01-13Body weight81.6kgS
2026-01-13Body mass index (BMI) [Ratio]24.4kg/m2S
2026-01-13Systolic blood pressure134mm[Hg]S
2026-01-13Diastolic blood pressure76mm[Hg]S
2026-01-13Heart rate70/minS
2026-01-13Respiratory rate14/minS
2026-01-13Body temperature36.6CelS
2026-01-13Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-01-13Hemoglobin [Mass/volume] in Blood13.8g/dL13.2-16.6 g/dLNormalS
2026-01-13Leukocytes [#/volume] in Blood by Automated count6.110*3/uL4-11 10*3/uLNormalS
2026-01-13Platelets [#/volume] in Blood by Automated count21410*3/uL150-400 10*3/uLNormalS
2026-01-13Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-01-13Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
2026-01-13Creatinine [Mass/volume] in Serum or Plasma1.04mg/dL0.74-1.35 mg/dLNormalS
2026-01-13Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M71mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-01-13Calcium [Mass/volume] in Serum or Plasma9.3mg/dL8.6-10.3 mg/dLNormalS
2026-01-13Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma19U/L7-55 U/LNormalS
2026-01-13Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma23U/L8-48 U/LNormalS
2026-01-13Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma76U/L40-129 U/LNormalS
2026-01-13Bilirubin.total [Mass/volume] in Serum or Plasma0.6mg/dL0.1-1.2 mg/dLNormalS
2026-01-13Albumin [Mass/volume] in Serum or Plasma4g/dL3.5-5 g/dLNormalS
2026-01-1325-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma24ng/mL30-100 ng/mLLowS
2026-01-13Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S

Problems

ProblemClinical statusVerificationCodeProvenance
Invasive ductal carcinoma of the right male breast, central (retroareolar) portion, stage IIA (pT1c pN1a M0), grade 2, ER positive, PR positive, HER2 negative; treated by bilateral mastectomy and right axillary lymph node dissection; on adjuvant tamoxifen; synthetic modern detail linked to his publicly disclosed breast canceractiveconfirmed C50.121S — Synthetic tumor size, grade, receptor status, and stage; the diagnosis, the right side, the operation, and the spread to lymph nodes are from his public account (D).
Estrogen receptor-positive status of the breast canceractiveconfirmed Z17.0S — Synthetic receptor result; his tumor biology was not made public.
Long-term use of tamoxifen, with safety monitoring (venous thromboembolism, mood, hot flashes, sexual side effects, adherence) and bone health reviewactiveconfirmed Z79.810S — Synthetic adjuvant therapy in the modern episode.
Absence of both breasts after bilateral mastectomyactiveconfirmed Z90.13S — The double mastectomy is reported publicly (D); the coding is synthetic.

Assessment

Plan of Treatment